← Back to Search

Supraglottic Airway Device

Endoscopic Retrograde Cholangiopancreatography for Cholangiocarcinoma

Q: Are there any openings currently available for this scientific trial?

<p>The clinical trial registry on clinicaltrials.gov reveals that this medical research endeavour is still open for enrollment, having been initiated in January 2021 and last updated in September 2022.</p>

Q: How many people have enrolled in this clinical trial thus far?

<p>Affirmative, the details accessible on clinicaltrials.gov demonstrate that this trial is vigorously enrolling participants at present. This study was first published on January 14th 2021 and last edited September 26th 2022. Sixty individuals will be accepted from a single medical centre for its duration.</p>

N/A

Waitlist Available

Led By Katherine Hagan

Research Sponsored by M.D. Anderson Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to completion of endoscopic retrograde cholangiopancreatography

Awards & highlights

Study Summary

This trial compares the LMA Gastro to oxygenation with standard nasal cannula for endoscopic retrograde cholangiopancreatography (ERCP).

Eligible Conditions

Cholangiocarcinoma
Gallbladder Cancer
Pancreatic Cancer

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to completion of endoscopic retrograde cholangiopancreatography

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to completion of endoscopic retrograde cholangiopancreatography

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to completion of endoscopic retrograde cholangiopancreatography for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Incidence of desaturations (oxygen saturation [SpO2] < 90%)

Secondary outcome measures

Incidence of additional airway maneuvers

Incidence of adverse events

Incidence of withdrawal of duodenoscope from airway to facilitate airway support

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Arm I (ERCP with LMA Gastro)Experimental Treatment1 Intervention

Patients undergo ERCP with LMA Gastro.

Group II: Arm II (ERCP with standard nasal cannula)Active Control1 Intervention

Patients undergo ERCP with standard nasal cannula.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Endoscopic Retrograde Cholangiopancreatography

2021

N/A

~100

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor

2,967 Previous Clinical Trials

1,804,736 Total Patients Enrolled

14 Trials studying Cholangiocarcinoma

3,999 Patients Enrolled for Cholangiocarcinoma

National Cancer Institute (NCI)NIH

13,657 Previous Clinical Trials

40,933,601 Total Patients Enrolled

102 Trials studying Cholangiocarcinoma

9,770 Patients Enrolled for Cholangiocarcinoma

Katherine HaganPrincipal InvestigatorM.D. Anderson Cancer Center

1 Previous Clinical Trials

33 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any openings currently available for this scientific trial?

"The clinical trial registry on clinicaltrials.gov reveals that this medical research endeavour is still open for enrollment, having been initiated in January 2021 and last updated in September 2022."

Answered by AI

How many people have enrolled in this clinical trial thus far?

"Affirmative, the details accessible on clinicaltrials.gov demonstrate that this trial is vigorously enrolling participants at present. This study was first published on January 14th 2021 and last edited September 26th 2022. Sixty individuals will be accepted from a single medical centre for its duration."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

A Dual Channel Supraglottic Airway Device (LMA Gastro) for Oxygenation in Patients Undergoing ERCP

2021. "A Dual Channel Supraglottic Airway Device (LMA Gastro) for Oxygenation in Patients Undergoing ERCP". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04740164.